Adult ADHD informed consent form template

Key takeaways

An adult ADHD consent form documents a patient’s informed agreement to ADHD assessment, diagnosis, and medication treatment with full understanding of risks and benefits.

Informed consent must cover baseline cardiovascular screening, stimulant medication risks (abuse potential, cardiovascular effects), non-stimulant alternatives, and the AAFP universal precautions framework.

Legal capacity for consent in adults with ADHD remains unimpaired unless a separate legal determination of incapacity exists. ADHD does not automatically remove consent rights.

Pabau’s digital forms and client portal allow clinicians to deliver, track, and store signed adults ADHD consent electronically with full HIPAA and GDPR compliance audit trails.

An adult ADHD consent form is a legal and clinical document that ensures patients understand the assessment process, diagnostic criteria, potential risks of medication, and their rights before treatment begins. Approximately 15.5 million adults in the United States have been diagnosed with ADHD (ICD-10 code F90), yet many clinicians lack a structured template that combines clinical accuracy with legal rigor.

Informed consent is a continuous process that documents patient understanding at every stage: initial assessment, diagnosis discussion, medication recommendation, and ongoing monitoring. Adults retain full legal capacity to consent even with ADHD, and clinicians must demonstrate that consent was freely given and based on adequate information about risks, benefits, and alternatives.

What is a consent form for adults ADHD assessment and medication?

A structured adults ADHD consent form serves three clinical and legal purposes. First, it documents that a patient understands the diagnostic process, covering DSM-5 criteria, behavioral history, psychological testing, and potential comorbid conditions.

Second, it discloses the risks and benefits of treatment options, including stimulant medications (methylphenidate, amphetamine-based drugs) and non-stimulant alternatives (atomoxetine).

Third, a structured consent form confirms the patient’s voluntary agreement and ongoing right to refuse or withdraw from treatment.

Regulatory bodies, including the FDA, DEA (which classifies stimulants as Schedule II controlled substances), and the AAFP, expect prescribers to document baseline cardiovascular risk screening and apply universal precautions for all ADHD patients before stimulant initiation. A robust consent form embeds these precautions into the patient engagement workflow rather than treating them as separate administrative tasks.

How to use an adults ADHD consent form template

Implementing an adults ADHD consent form follows five operational steps in clinical practice:

1. Initiate at first assessment: Deliver the form during the initial appointment, before formal diagnostic discussion and often alongside a standardized ADHD screening test. Explain that informed consent is a process, not a one-time checkbox, and allow the patient time to read and ask questions without pressure.
2. Document baseline cardiovascular risk: Ask about personal or family history of sudden cardiac death, arrhythmias, hypertension, or structural heart disease. Note any contraindications to stimulant use (active substance use disorders, uncontrolled hypertension, recent cardiac events). The form should require clinician attestation that baseline screening was completed.
3. Discuss medication risks and benefits: Review the specific medication class being considered. Stimulants carry risks of appetite suppression, sleep disruption, elevated blood pressure, and potential for misuse (see ICD-10 code F15.20 for stimulant dependence); non-stimulants offer lower abuse potential but slower onset and variable efficacy. Document which options were presented and which the patient selected.
4. Obtain signature and witness attestation: Have the patient sign confirming they understood the information, had the opportunity to ask questions, and voluntarily agree to proceed. Include a clinician signature and ideally a witness (staff member or family member present) to strengthen legal defensibility if treatment is later disputed.
5. Store electronically with audit trail: Use a practice management system with digital form storage to retain signed consent with timestamps, access logs, and audit trails. HIPAA and GDPR compliance requires proof that the document was stored securely and accessed only by authorized personnel.

The consent form should be re-signed or re-reviewed annually or whenever treatment changes, such as a medication adjustment, dose change, or switch to a different drug class. A structured change plan worksheet can help document why a treatment change was made alongside the updated consent. A single-time consent does not cover ongoing prescribing decisions.

Streamline clinical compliance with digital forms

Store signed adults ADHD consent forms securely with full HIPAA and GDPR audit trails. Pabau's digital forms auto-populate patient data and generate instant compliance records.

Book a demo

Who is an adults ADHD consent form helpful for?

Adults ADHD consent templates serve psychiatrists, family medicine practitioners, nurse practitioners, and physician assistants prescribing in private practice, urgent care, and integrated primary care settings, consistent with the AAFP’s adult ADHD guidance.

They are equally essential for ADHD coaching practices using a structured ADHD treatment plan, therapists conducting comprehensive ADHD assessments (even without prescribing), and occupational health practices evaluating workplace accommodations linked to ADHD diagnosis.

Any practice managing adult ADHD, whether medication-focused or behavioral/coaching-focused, benefits from a structured consent process. Solo practitioners and multi-location practices alike face legal exposure if diagnosis and treatment decisions are not documented as informed decisions made by the patient.

Benefits of using an adults ADHD informed consent form

A comprehensive adults ADHD consent form delivers five operational and legal benefits:

• Legal defensibility: Documented informed consent is the gold standard defense in malpractice cases. If a patient later claims they did not understand medication risks or did not consent to treatment, a signed, witnessed form with baseline risk screening notes proves the standard of care was met.
• Regulatory compliance: The AAFP Adult ADHD Toolkit requires informed consent as part of universal precautions. CMS and private insurers increasingly audit for consent documentation, and practices without it risk audit findings and payment recapture; a HIPAA compliance checklist can help confirm the consent record meets those standards.
• Reduced medication misuse: A consent form that explicitly addresses Schedule II controlled substance prescribing, abuse potential, and monitoring expectations clarifies expectations upfront. Patients who have signed are more likely to comply with urine drug screening and refill limits, and clinicians can pair the form with an ADHD screening CPT code when billing the assessment visit.
• Improved patient safety: Consent forms that require baseline cardiovascular screening, supported by data from an adult ADHD self-report scale, prevent prescription of stimulants to high-risk patients, reducing sudden cardiac death risk.
• Workflow efficiency: A digital consent form auto-populated with patient demographics, medication list, and comorbidity data saves clinician time, and pairing it with e-prescribing software keeps the full medication record consistent across visits.

DSM-5 diagnostic criteria and consent documentation

An effective adults ADHD consent form grounds the consent process in the DSM-5 diagnostic framework. Under DSM-5, an individual diagnosed with ADHD must experience a persistent pattern of clinically significant symptoms that meaningfully interfere with functioning, not just the presence of inattention or hyperactivity.

A consent form should explicitly state which symptoms the clinician observed, which developmental history supports the diagnosis, and which standardized rating scales, such as the Conners scale or the Vanderbilt ADHD rating scale, or psychological testing was used to reach the diagnosis.

Patients often ask: “Why am I only being diagnosed now?” A consent form that addresses the high prevalence of adult ADHD diagnosis, and explains why childhood symptoms may have been masked by coping mechanisms, intelligence, or a comorbid condition tracked on an anxiety fact sheet, normalizes the diagnosis and increases patient confidence in the assessment process.

This educational component reduces post-diagnosis regret and improves medication adherence.

AAFP universal precautions and baseline risk stratification

The AAFP Adult ADHD Toolkit mandates universal precautions for every patient prescribed ADHD stimulants. A clinical-grade consent form must embed this three-part framework:

1. Careful diagnosis and consideration of indications, contraindications, and comorbidities: list red flags such as active substance abuse, uncontrolled bipolar disorder, or recent cardiac events that contraindicate stimulants.
2. Baseline risk stratification: document personal and family history of sudden cardiac death, blood pressure, resting heart rate, and use of other medications that interact with stimulants.
3. Informed consent and ongoing monitoring: disclose that the patient will have follow-up appointments, periodic cardiovascular checks, and urine drug screens if risk is elevated.

Many adult ADHD patients also have comorbid anxiety, depression, or substance use disorders, which complicate consent. The form should ask whether the patient has ever misused prescription medications, struggled with alcohol use, or experienced cardiac symptoms.

A clinician’s documented response to these disclosures (for example, “patient reports prior opioid misuse; will use cautious dosing and monthly monitoring”) becomes part of the informed consent narrative and shows that risk was identified and mitigated.

Ensuring HIPAA and GDPR compliance in consent documentation

A consent form is itself a medical record subject to HIPAA (US) and GDPR (EU/UK) regulations. The form must include a data privacy notice explaining how the patient’s information will be stored, who has access, how long it will be retained, and the patient’s right to request deletion or correction.

Some practices pair this with a separate HIPAA authorization form when consent data will be shared with outside labs or referring specialists, plus a checkbox stating: “I understand my health information will be stored securely and accessed only by authorized practice staff.”

When storing signed consent forms in practice management software, ensure the platform logs all access, meaning who viewed the form, when, and from which device. GDPR specifically requires an audit trail.

Practices that also use a mental health intake form should store both documents together so the full clinical picture stays linked. A paper-based consent form stored in an unlocked file cabinet creates compliance risk; digital storage with timestamp and access logs mitigates liability.

Conclusion

An adults ADHD informed consent form is the cornerstone of evidence-based, ethical ADHD care, not a legal afterthought. A well-designed template documents diagnosis, discloses medication risks and alternatives per AAFP universal precautions, confirms baseline cardiovascular screening, and provides a legal record that treatment decisions were shared and voluntary.

Pabau’s digital forms and client portal allow clinicians to deliver consent workflows electronically with built-in HIPAA compliance and secure audit trails, transforming consent from a paper burden into a streamlined clinical touchpoint that strengthens both patient safety and legal defensibility. Book a demo to see Pabau in action.

Continue your research

Need guidance on ADHD assessment workflows? Patient portal for self-directed ADHD screening questionnaires helps clinicians deliver validated screening tools (Conners, ASRS) before the first visit, reducing assessment time and improving diagnostic accuracy.

Looking for a framework to document ADHD comorbidities? Psychiatric evaluation template covers depression, anxiety, substance use, and ADHD in a single comprehensive assessment structure designed for private practices.

Want to simplify digital consent delivery? Pabau’s AI medical scribe auto-generates consent summaries and risk assessment notes from clinician documentation, saving time on consent preparation.

Frequently asked questions